May 13, 2019 — A digital screening for atrial fibrillation (AFib or AF) successfully monitored more than 60,000 participants from the general population in Belgium using only a smartphone. The results of the late-breaking DIGITAL-AF II study were presented at Heart Rhythm 2019, the Heart Rhythm Society's 40th annual Scientific Sessions.

BioTrace Medical Inc. announced the company’s Tempo Lead has obtained CE Mark certification in Europe for use in cardiac procedures requiring temporary intracardiac pacing.

AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L the world's first available six-lead personal electrocardiogram (ECG) device, according to the company. This clearance gives patients and their physicians an even more detailed view into patients' hearts, including visibility into certain arrhythmias that are leading indicators of cardiovascular disease.

Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a magnetic resonance imaging (MRI) ablation center for treating cardiac arrhythmias.


The integration of artificial intelligence (AI) into medicine has by far been the hottest topic at nearly all medical conferences for radiology, cardiology and several other subspecialties over the past two years. This has led to the creation of an organization AIMed to help spearhead collaboration and dissemination of information on AI developments to speed its adoption. 


Catheter Interventions in Congenital, Structural and Valvular Heart Disease (CSI)

Shine Medical Technologies Inc. broke ground on their first medical isotope production facility in Janesville, Wis. U.S. Department of Energy (DOE) Under Secretary for Nuclear Security and Administrator of the National Nuclear Security Administration (NNSA) Lisa Gordon-Hagerty, Lantheus Medical Imaging President and CEO Mary Heino and Janesville City Manager Mark Freitag joined Shine founder and CEO, Greg Piefer, and the Shine team to celebrate the milestone.

Spacelabs Healthcare debuted Sentinel 11 at the 40th Annual Heart Rhythm Society (HRS) Scientific Sessions, May 8-11, 2019, in San Francisco. This latest release from Spacelabs advances cardiology information management with optimized workflows, expanded connectivity and robust data security capabilities.


May 10, 2019 — Here is the list of the late-breaking hot line studies being presented at the 2019 EuroPCR interventional cardiology meeting, May 21-24, in Paris, France.

EuroPCR 2019 Hot Line and Trial Update
Tuesday May 21, 12:00 - 13:15, Main Arena, Level 1
   • Mitral regurgitation after MitraClip implantation: relationship between residual mitral regurgitation and clinical and functional outcomes from the COAPT trial. Presented by S. Kar.


Subscribe Now